Article Details
Retrieved on: 2024-07-12 17:13:50
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article highlights biotech advancements in diabetes care, including peptide-based treatments like semaglutide and inhaled insulin, automated insulin delivery systems, and fenofibrate for diabetic retinopathy. The tags reflect the study's focus on these innovations and their impacts.
Article found on: www.endocrinologyadvisor.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here